These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

720 related items for PubMed ID: 16908620

  • 1. Erythropoietin concentrations and neurodevelopmental outcome in preterm infants.
    Bierer R, Peceny MC, Hartenberger CH, Ohls RK.
    Pediatrics; 2006 Sep; 118(3):e635-40. PubMed ID: 16908620
    [Abstract] [Full Text] [Related]

  • 2. Neurodevelopmental outcome and growth at 18 to 22 months' corrected age in extremely low birth weight infants treated with early erythropoietin and iron.
    Ohls RK, Ehrenkranz RA, Das A, Dusick AM, Yolton K, Romano E, Delaney-Black V, Papile LA, Simon NP, Steichen JJ, Lee KG, National Institute of Child Health and Human Development Neonatal Research Network.
    Pediatrics; 2004 Nov; 114(5):1287-91. PubMed ID: 15520109
    [Abstract] [Full Text] [Related]

  • 3. Beneficial effects of breast milk in the neonatal intensive care unit on the developmental outcome of extremely low birth weight infants at 18 months of age.
    Vohr BR, Poindexter BB, Dusick AM, McKinley LT, Wright LL, Langer JC, Poole WK, NICHD Neonatal Research Network.
    Pediatrics; 2006 Jul; 118(1):e115-23. PubMed ID: 16818526
    [Abstract] [Full Text] [Related]

  • 4. Higher cumulative doses of erythropoietin and developmental outcomes in preterm infants.
    Brown MS, Eichorst D, Lala-Black B, Gonzalez R.
    Pediatrics; 2009 Oct; 124(4):e681-7. PubMed ID: 19786428
    [Abstract] [Full Text] [Related]

  • 5. Changes in neurodevelopmental outcomes at 18 to 22 months' corrected age among infants of less than 25 weeks' gestational age born in 1993-1999.
    Hintz SR, Kendrick DE, Vohr BR, Poole WK, Higgins RD, National Institute of Child Health and Human Development Neonatal Research Network.
    Pediatrics; 2005 Jun; 115(6):1645-51. PubMed ID: 15930228
    [Abstract] [Full Text] [Related]

  • 6. Neurodevelopmental outcomes of extremely low birth weight infants <32 weeks' gestation between 1993 and 1998.
    Vohr BR, Wright LL, Poole WK, McDonald SA.
    Pediatrics; 2005 Sep; 116(3):635-43. PubMed ID: 16143580
    [Abstract] [Full Text] [Related]

  • 7. A phase I/II trial of high-dose erythropoietin in extremely low birth weight infants: pharmacokinetics and safety.
    Juul SE, McPherson RJ, Bauer LA, Ledbetter KJ, Gleason CA, Mayock DE.
    Pediatrics; 2008 Aug; 122(2):383-91. PubMed ID: 18676557
    [Abstract] [Full Text] [Related]

  • 8. An approach to using recombinant erythropoietin for neuroprotection in very preterm infants.
    Fauchère JC, Dame C, Vonthein R, Koller B, Arri S, Wolf M, Bucher HU.
    Pediatrics; 2008 Aug; 122(2):375-82. PubMed ID: 18676556
    [Abstract] [Full Text] [Related]

  • 9. Follow-up outcomes at 1 and 2 years of infants born less than 32 weeks after Newborn Individualized Developmental Care and Assessment Program.
    Maguire CM, Walther FJ, van Zwieten PH, Le Cessie S, Wit JM, Veen S.
    Pediatrics; 2009 Apr; 123(4):1081-7. PubMed ID: 19336365
    [Abstract] [Full Text] [Related]

  • 10. Neurodevelopmental and growth outcomes of extremely low birth weight infants after necrotizing enterocolitis.
    Hintz SR, Kendrick DE, Stoll BJ, Vohr BR, Fanaroff AA, Donovan EF, Poole WK, Blakely ML, Wright L, Higgins R, NICHD Neonatal Research Network.
    Pediatrics; 2005 Mar; 115(3):696-703. PubMed ID: 15741374
    [Abstract] [Full Text] [Related]

  • 11. Major congenital anomalies place extremely low birth weight infants at higher risk for poor growth and developmental outcomes.
    Walden RV, Taylor SC, Hansen NI, Poole WK, Stoll BJ, Abuelo D, Vohr BR, National Institute of Child Health and Human Development Neonatal Research Network.
    Pediatrics; 2007 Dec; 120(6):e1512-9. PubMed ID: 17984212
    [Abstract] [Full Text] [Related]

  • 12. Neurodevelopmental outcome of extremely low birth weight infants randomly assigned to restrictive or liberal hemoglobin thresholds for blood transfusion.
    Whyte RK, Kirpalani H, Asztalos EV, Andersen C, Blajchman M, Heddle N, LaCorte M, Robertson CM, Clarke MC, Vincer MJ, Doyle LW, Roberts RS, PINTOS Study Group.
    Pediatrics; 2009 Jan; 123(1):207-13. PubMed ID: 19117884
    [Abstract] [Full Text] [Related]

  • 13. Vitamin A supplementation for extremely low birth weight infants: outcome at 18 to 22 months.
    Ambalavanan N, Tyson JE, Kennedy KA, Hansen NI, Vohr BR, Wright LL, Carlo WA, National Institute of Child Health and Human Development Neonatal Research Network.
    Pediatrics; 2005 Mar; 115(3):e249-54. PubMed ID: 15713907
    [Abstract] [Full Text] [Related]

  • 14. Persistent beneficial effects of breast milk ingested in the neonatal intensive care unit on outcomes of extremely low birth weight infants at 30 months of age.
    Vohr BR, Poindexter BB, Dusick AM, McKinley LT, Higgins RD, Langer JC, Poole WK, National Institute of Child Health and Human Development National Research Network.
    Pediatrics; 2007 Oct; 120(4):e953-9. PubMed ID: 17908750
    [Abstract] [Full Text] [Related]

  • 15. Validation of the National Institutes of Health consensus definition of bronchopulmonary dysplasia.
    Ehrenkranz RA, Walsh MC, Vohr BR, Jobe AH, Wright LL, Fanaroff AA, Wrage LA, Poole K, National Institutes of Child Health and Human Development Neonatal Research Network.
    Pediatrics; 2005 Dec; 116(6):1353-60. PubMed ID: 16322158
    [Abstract] [Full Text] [Related]

  • 16. Effect of chorioamnionitis on neurodevelopmental outcome in preterm infants.
    Polam S, Koons A, Anwar M, Shen-Schwarz S, Hegyi T.
    Arch Pediatr Adolesc Med; 2005 Nov; 159(11):1032-5. PubMed ID: 16275792
    [Abstract] [Full Text] [Related]

  • 17. Lack of effects of oral probiotics on growth and neurodevelopmental outcomes in preterm very low birth weight infants.
    Chou IC, Kuo HT, Chang JS, Wu SF, Chiu HY, Su BH, Lin HC.
    J Pediatr; 2010 Mar; 156(3):393-6. PubMed ID: 19914635
    [Abstract] [Full Text] [Related]

  • 18. Neurodevelopmental outcome of very-low-birth-weight infants with chorioamnionitis.
    Mu SC, Lin CH, Sung TC, Chen YL, Lin YC, Lee CC, Chen TJ, Lin MI, Jow GM.
    Acta Paediatr Taiwan; 2007 Mar; 48(4):207-12. PubMed ID: 18265542
    [Abstract] [Full Text] [Related]

  • 19. Grades I-II intraventricular hemorrhage in extremely low birth weight infants: effects on neurodevelopment.
    Patra K, Wilson-Costello D, Taylor HG, Mercuri-Minich N, Hack M.
    J Pediatr; 2006 Aug; 149(2):169-73. PubMed ID: 16887428
    [Abstract] [Full Text] [Related]

  • 20. Effects of thyroxine supplementation on neurologic development in infants born at less than 30 weeks' gestation.
    van Wassenaer AG, Kok JH, de Vijlder JJ, Briët JM, Smit BJ, Tamminga P, van Baar A, Dekker FW, Vulsma T.
    N Engl J Med; 1997 Jan 02; 336(1):21-6. PubMed ID: 8970936
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 36.